NZX50 slides to nine-month low

NZX50 slides to nine-month low
A new drug has weighed on Fisher and Paykel's shares. (Image: Getty)
Graham Skellern
A weight-reducing drug is causing trouble for Fisher and Paykel Healthcare as the New Zealand sharemarket chalked up its sixth successive fall.The S&P/NZX 50 Index was on a downward slide all day and closed at 11,344.11, down 82.73 points or 0.72% – its lowest level for nine months.The index has now fallen 1.8% for the year and was at 11308.31 points on November 28.There were 42 gainers and 84 decliners on the main board, with 28.19 million shares worth $102.5m changing hands.Under pressureMarket heavyweight Fisher and Paykel Healthca...

More Markets

Comvita buzzing after takeover bid; NZX 50 up 0.6%
Markets Market Close

Comvita buzzing after takeover bid; NZX 50 up 0.6%

The a2 Milk Company dominated volumes.

Baby Bunting's NZ teething over, posts earnings growth
Retail

Baby Bunting's NZ teething over, posts earnings growth

Baby Bunting plans to open its fifth New Zealand store by year-end.

Contact reports strong profit in tough conditions
Markets

Contact reports strong profit in tough conditions

Geothermal and gas positions offset fall in hydro generation.

Freightways outpaces flat NZ economy with 12.9% profit lift
Markets

Freightways outpaces flat NZ economy with 12.9% profit lift

More than a third of profits now come from across the Tasman.